96 related articles for article (PubMed ID: 9257329)
1. Radiation dosimetry of [18F] (N-methyl)benperidol as determined by whole-body PET imaging of primates.
Moerlein SM; Perlmutter JS; Cutler PD; Welch MJ
Nucl Med Biol; 1997 May; 24(4):311-8. PubMed ID: 9257329
[TBL] [Abstract][Full Text] [Related]
2. Radiation dosimetry of N-([11C]methyl)benperidol as determined by whole-body PET imaging of primates.
Antenor-Dorsey JA; Laforest R; Moerlein SM; Videen TO; Perlmutter JS
Eur J Nucl Med Mol Imaging; 2008 Apr; 35(4):771-8. PubMed ID: 18071701
[TBL] [Abstract][Full Text] [Related]
3. In vivo kinetics of [18F](N-methyl)benperidol: a novel PET tracer for assessment of dopaminergic D2-like receptor binding.
Moerlein SM; Perlmutter JS; Markham J; Welch MJ
J Cereb Blood Flow Metab; 1997 Aug; 17(8):833-45. PubMed ID: 9290581
[TBL] [Abstract][Full Text] [Related]
4. Production of fluorine-18 labeled (3-N-methyl)benperidol for PET investigation of cerebral dopaminergic receptor binding.
Moerlein SM; Banks WR; Parkinson D
Int J Rad Appl Instrum A; 1992 Jul; 43(7):913-7. PubMed ID: 1321101
[TBL] [Abstract][Full Text] [Related]
5. Specific, reversible binding of [18F]benperidol to baboon D2 receptors: PET evaluation of an improved 18F-labeled ligand.
Moerlein SM; Perlmutter JS; Welch MJ
Nucl Med Biol; 1995 Aug; 22(6):809-15. PubMed ID: 8535343
[TBL] [Abstract][Full Text] [Related]
6. In vivo labeling of the dopamine D2 receptor with N-11C-methyl-benperidol.
Suehiro M; Dannals RF; Scheffel U; Stathis M; Wilson AA; Ravert HT; Villemagne VL; Sanchez-Roa PM; Wagner HN
J Nucl Med; 1990 Dec; 31(12):2015-21. PubMed ID: 2148346
[TBL] [Abstract][Full Text] [Related]
7. Whole-body biodistribution, radiation dosimetry estimates for the PET norepinephrine transporter probe (S,S)-[18F]FMeNER-D2 in non-human primates.
Seneca N; Andree B; Sjoholm N; Schou M; Pauli S; Mozley PD; Stubbs JB; Liow JS; Sovago J; Gulyás B; Innis R; Halldin C
Nucl Med Commun; 2005 Aug; 26(8):695-700. PubMed ID: 16000987
[TBL] [Abstract][Full Text] [Related]
8. Specific binding of 3N-(2'-[18F]fluoroethyl)benperidol to primate cerebral dopaminergic D2 receptors demonstrated in vivo by PET.
Moerlein SM; Perlmutter JS
Neurosci Lett; 1992 Dec; 148(1-2):97-100. PubMed ID: 1300511
[TBL] [Abstract][Full Text] [Related]
9. In vivo measurement of D2 receptor density and affinity for 18F-(3-N-methyl)benperidol in the rat striatum with a PET system for small laboratory animals.
Nikolaus S; Larisch R; Beu M; Hamacher K; Forutan F; Vosberg H; Müller HW
J Nucl Med; 2003 Apr; 44(4):618-24. PubMed ID: 12679408
[TBL] [Abstract][Full Text] [Related]
10. 18F-Fluorothymidine radiation dosimetry in human PET imaging studies.
Vesselle H; Grierson J; Peterson LM; Muzi M; Mankoff DA; Krohn KA
J Nucl Med; 2003 Sep; 44(9):1482-8. PubMed ID: 12960196
[TBL] [Abstract][Full Text] [Related]
11. Whole-body radiation dosimetry of 2-[18F]Fluoro-A-85380 in human PET imaging studies.
Obrzut SL; Koren AO; Mandelkern MA; Brody AL; Hoh CK; London ED
Nucl Med Biol; 2005 Nov; 32(8):869-74. PubMed ID: 16253812
[TBL] [Abstract][Full Text] [Related]
12. [18F]fluoroestradiol radiation dosimetry in human PET studies.
Mankoff DA; Peterson LM; Tewson TJ; Link JM; Gralow JR; Graham MM; Krohn KA
J Nucl Med; 2001 Apr; 42(4):679-84. PubMed ID: 11337559
[TBL] [Abstract][Full Text] [Related]
13. Biodistribution and radiation dosimetry of [11C]DASB in baboons.
Bélanger MJ; Simpson NR; Wang T; Van Heertum RL; Mann JJ; Parsey RV
Nucl Med Biol; 2004 Nov; 31(8):1097-102. PubMed ID: 15607492
[TBL] [Abstract][Full Text] [Related]
14. Estimation of absorbed dose for 2-[F-18]fluoro-2-deoxy-D-glucose using whole-body positron emission tomography and magnetic resonance imaging.
Deloar HM; Fujiwara T; Shidahara M; Nakamura T; Watabe H; Narita Y; Itoh M; Miyake M; Watanuki S
Eur J Nucl Med; 1998 Jun; 25(6):565-74. PubMed ID: 9618570
[TBL] [Abstract][Full Text] [Related]
15. Biodistribution and radiation dosimetry of radioiodinated-SCH 23982, a potential dopamine D-1 receptor imaging agent.
Thonoor CM; Couch MW; Greer DM; Thomas KD; Williams CM
J Nucl Med; 1988 Oct; 29(10):1668-74. PubMed ID: 3262726
[TBL] [Abstract][Full Text] [Related]
16. Biodistribution and radiation dosimetry of the serotonin transporter ligand 11C-DASB determined from human whole-body PET.
Lu JQ; Ichise M; Liow JS; Ghose S; Vines D; Innis RB
J Nucl Med; 2004 Sep; 45(9):1555-9. PubMed ID: 15347724
[TBL] [Abstract][Full Text] [Related]
17. Biodistribution and Radiation Dosimetry of
Garg PK; Lokitz SJ; Nazih R; Garg S
J Nucl Med; 2017 Mar; 58(3):473-478. PubMed ID: 27660145
[TBL] [Abstract][Full Text] [Related]
18. Estimation of absorbed doses in humans due to intravenous administration of fluorine-18-fluorodeoxyglucose in PET studies.
Mejia AA; Nakamura T; Masatoshi I; Hatazawa J; Masaki M; Watanuki S
J Nucl Med; 1991 Apr; 32(4):699-706. PubMed ID: 2013810
[TBL] [Abstract][Full Text] [Related]
19. Radiation dosimetry estimates for the PET serotonin transporter probe 11C-DASB determined from whole-body imaging in non-human primates.
Tipre DN; Lu JQ; Fujita M; Ichise M; Vines D; Innis RB
Nucl Med Commun; 2004 Jan; 25(1):81-6. PubMed ID: 15061269
[TBL] [Abstract][Full Text] [Related]
20. The radiation dosimetry of 2 [F-18]fluoro-2-deoxy-D-glucose in man.
Jones SC; Alavi A; Christman D; Montanez I; Wolf AP; Reivich M
J Nucl Med; 1982 Jul; 23(7):613-7. PubMed ID: 6979616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
